Experimental Biology and Medicine

Oncology & Cancer

Targeting cancer cells with an implantable drug delivery system

An article published in Experimental Biology and Medicine (Volume 242, Issue 7, March, 2017) describes a new drug delivery system for the treatment of cancer. The study, led by Dr. Horst A. von Recum from the Department of ...

Oncology & Cancer

Suppressing vasculogenic mimicry in breast cancer

An article published in Experimental Biology and Medicine (Volume 242, Issue 6, March, 2017) identifies a new signaling pathway involved in breast cancer cell growth. The study, led by Dr. Chan-Wha Kim, from the Department ...

Genetics

Researchers find potential treatments for hemoglobinopathies

An article published in Experimental Biology and Medicine (Volume 242, Issue 3, February, 2017) identifies microRNAs (miRNAs) as key factors in some hemoglobinopathies, genetic disorders characterized by alterations in the ...

Cardiology

Cardioprotective effects of lysyl oxidase inhibition

Heart failure is a progressive condition, where structural and functional alterations of the ventricle limit the ability of the heart to either fill or eject blood. There are approximately 550,000 new cases of heart failure ...

Medical research

Nuclear export of opioid growth factor receptor is CRM1 dependent

In a study in the February 2016 Issue (241:3) of Experimental Biology and Medicine researchers at The Pennsylvania State University College of Medicine, led by Dr. Pat McLaughlin, discovered that a novel biological pathway, ...

page 3 from 7